Kobayashi Pharmaceutical Co (TSE:4967) COGS-to-Revenue : 0.43 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co COGS-to-Revenue?

Kobayashi Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was 円15,534 Mil. Its Revenue for the three months ended in Mar. 2024 was 円36,485 Mil.

Kobayashi Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.43.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Kobayashi Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 was 57.42%.

Kobayashi Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co COGS-to-Revenue Chart

Kobayashi Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.43

0.44

Kobayashi Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.42	0.42	0.44	0.48	0.43

Kobayashi Pharmaceutical Co COGS-to-Revenue Calculation

Kobayashi Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	77080	/	173455
	=	0.44

Kobayashi Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	15534	/	36485
	=	0.43

Kobayashi Pharmaceutical Co (TSE:4967) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Kobayashi Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	15534 / 36485
	=	57.42 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Kobayashi Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

KOY:Germany

Address

KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.kobayashi.co.jp

Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines